Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A beginner's guide to NF-kappaB signaling pathways.

Sylvie Delhalle1, Romain Blasius, Mario Dicato

  • 1Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, L-2540 Luxembourg, Luxembourg.

Annals of the New York Academy of Sciences
|January 22, 2005
PubMed
Summary

Nuclear factor kappaB (NF-kappaB) is crucial for inflammation, stress, and cancer survival. Inhibiting NF-kappaB offers potential therapeutic benefits by blocking key gene transcription.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

OT-55 reshapes tolerogenic BH3-mimetic-induced apoptosis toward immunogenic cell death in acute myeloid leukemia, potentiating PD-1/Tim-3 blockade.

Cell death & disease·2026
Same author

Selective HDAC6 inhibition perturbs autophagy and enhances integrated stress response-mediated immunogenic apoptosis in chronic myeloid leukemia.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemia.

Cancer letters·2025
Same author

Martinostat as a novel HDAC inhibitor to overcome tyrosine kinase inhibitor resistance in chronic myeloid leukemia.

Clinical epigenetics·2025
Same author

Author Correction: A roadmap towards personalized immunology.

NPJ systems biology and applications·2025
Same author

Marine Natural Products as Anticancer Agents 3.0.

Marine drugs·2025

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Immunology

Background:

  • Nuclear factor kappaB (NF-kappaB) is a transcription factor family involved in inflammatory and stress responses.
  • NF-kappaB regulates genes critical for cell survival and apoptosis resistance, particularly in tumor cells.
  • Its role in cellular responses to environmental conditions is well-established.

Purpose of the Study:

  • To summarize the therapeutic advantages of inhibiting Nuclear factor kappaB (NF-kappaB) activity.
  • To review the molecular targets within NF-kappaB signaling pathways.
  • To highlight promising compounds for NF-kappaB inhibition.

Main Methods:

  • Review of existing scientific literature on NF-kappaB signaling.
  • Analysis of signal transduction pathways leading to NF-kappaB activation.

Related Experiment Videos

  • Evaluation of various NF-kappaB inhibitors and their potential.

    • Main Results:

    • NF-kappaB dependent transcription drives proinflammatory and antiapoptotic gene expression.
    • Signal transduction pathways offer multiple protein targets for NF-kappaB inhibition.
    • Several novel compounds demonstrate promise as NF-kappaB inhibitors.

    Conclusions:

    • Targeting NF-kappaB presents a viable therapeutic strategy for inflammatory diseases and cancer.
    • Further research into NF-kappaB inhibitors can yield significant clinical benefits.
    • Understanding NF-kappaB pathways is key to developing effective treatments.